Where can researchers source third-party tested GHK-Cu?

Midwest Peptide supplies research-grade GHK-Cu with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Free shipping on every orderFree shipping on every order

5% off when you pay with ZelleSave an extra 5% when you pay with Zelle

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

GHK-Cu 50mg in Research: Applications and Key Findings | Midwest Peptide

Where to Buy GLP-1 Research Peptides: Sourcing GuidePrev|GLP3RT Research: Structure, Mechanism, and Preclinical UsesNext

GHK-Cu 50mg in Research: Applications, Stability, and Findings

GHK-Cu · Published April 29, 2026 · Updated May 18, 2026 · 7 min read

Quick Answer

GHK-Cu 50mg is a research-grade copper tripeptide used in laboratory studies of extracellular matrix biology, dermal fibroblast activity, and tissue remodeling. Researchers source it for cell-culture and animal-model investigation of collagen synthesis, antioxidant signaling, and gene expression. For research use only, not for human or veterinary application.

GHK-Cu 50mg in Research: Applications, Stability, and Findings

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

What Is GHK-Cu and Why Is the 50mg Format Used in Research?
How Is GHK-Cu Stable Under Laboratory Storage Conditions?
What Mechanisms Does GHK-Cu Engage in Preclinical Models?
What Are the Main Preclinical Applications of GHK-Cu 50mg?
How Does GHK-Cu Compare to Other Copper Peptides in Research?
What Should Researchers Consider When Sourcing GHK-Cu 50mg?
Frequently Asked Questions
Related Research Reading
Frequently Asked Questions
Glossary

GHK-Cu 50mg is a packaging format for the research peptide GHK copper, a naturally occurring tripeptide complexed with a copper(II) ion. The 50mg vial size has become the standard preclinical research unit because it covers a typical study course at the concentrations used in cell-culture and animal-model work. In the broader literature, GHK-Cu is studied for its measurable effects on extracellular matrix biology, dermal fibroblast activity, antioxidant signaling, and tissue remodeling pathways. For an entry into the cluster this peptide sits within, see our comprehensive GHK-Cu copper peptide literature review and the GHK-Cu collagen synthesis dermal fibroblast research overview.

Frequently Asked Questions

What is GHK-Cu in research contexts?

GHK-Cu is a copper-bound tripeptide composed of glycine, histidine, and lysine complexed with a Cu(II) ion. It occurs naturally in human plasma and is studied in preclinical models for collagen synthesis, dermal fibroblast activity, and tissue regeneration.

How is GHK-Cu 50mg used in research?

The 50mg vial size is common for chronic dosing studies in rodent models or extended cell culture experiments, providing enough material for multi-week protocols of dermal repair, collagen synthesis, or wound healing research without batch-to-batch variation.

How stable is reconstituted GHK-Cu in research?

Reconstituted GHK-Cu is stable for approximately 30 days under refrigeration in bacteriostatic water, with the copper-peptide complex retaining biological activity. Avoid freeze-thaw cycles that may dissociate the copper from the peptide carrier.

Is GHK-Cu approved for human use?

No. GHK-Cu is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Glossary

Key terms used in this article.

Copper Peptide: A peptide that chelates copper ions, often Cu(II), to form a biologically active complex.
Dermal Fibroblast: A skin connective tissue cell that produces collagen, elastin, and extracellular matrix components.
Procollagen: The precursor molecule that is processed into mature collagen fibers in the extracellular matrix.
Extracellular Matrix (ECM): The non-cellular network of structural and biochemical molecules that supports tissue architecture.
Wound Healing: The biological process of tissue repair following injury, comprising hemostasis, inflammation, proliferation, and remodeling.
Cu(II) Ion: The divalent copper cation that complexes with the GHK tripeptide to form the biologically active GHK-Cu species.
Freeze-Thaw Cycle: Repeated freezing and thawing of a peptide solution that can degrade activity through aggregation and oxidative damage.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

For Research Use Only. GHK-Cu is intended exclusively for laboratory research. It is not approved for human or veterinary use and should never be administered to humans or animals outside of a controlled research setting.

What Is GHK-Cu and Why Is the 50mg Format Used in Research?

GHK is a tripeptide composed of glycine, histidine, and lysine in the sequence Gly-His-Lys, naturally present in human plasma and other biological fluids. The peptide carries a high affinity for copper(II) ions, and the resulting GHK-Cu complex is the form most commonly studied in preclinical research. The 50mg format gives investigators enough material to run multiple cell-culture passages or a small-cohort animal-model study without repeated reconstitution, which keeps batch and storage variables consistent across an experiment. Background on copper-peptide coordination chemistry is documented across the ScienceDirect copper peptide topic page. For sourcing the format directly, see the GHK-Cu product page.

How Is GHK-Cu Stable Under Laboratory Storage Conditions?

Lyophilized GHK-Cu shows good stability when stored frozen, protected from light and moisture, in a sealed container with desiccant. Once reconstituted in bacteriostatic water or another approved diluent, the solution is typically refrigerated at 2 to 8 degrees Celsius and used within the supplier's documented stability window, which spans a few weeks under proper handling. Stability is primarily limited by oxidation of the copper coordination sphere and slow hydrolysis of the peptide backbone in solution, so minimizing freeze-thaw cycles and limiting light exposure both extend usable life. The chemistry of peptide-metal complex stability is reviewed in the Wiley Online Library coordination chemistry collection and across Frontiers in Chemistry.

What Mechanisms Does GHK-Cu Engage in Preclinical Models?

GHK-Cu engages multiple intracellular mechanisms in research models. Cell-culture studies in dermal fibroblasts show measurable changes in collagen and elastin gene expression, increased glycosaminoglycan production, and altered matrix metalloproteinase activity, which together influence extracellular matrix turnover. The copper-coordinated complex appears to participate in superoxide dismutase-like activity and influences cellular antioxidant signaling, with research published across Cell Reports characterizing redox-related mechanisms. Gene expression studies in cultured cells show GHK-Cu modulating hundreds of transcripts in panels covering ECM biology, cellular stress response, and tissue remodeling, as detailed in our GHK-Cu transcriptomic research overview.

What Are the Main Preclinical Applications of GHK-Cu 50mg?

GHK-Cu in the 50mg research format is used in three main preclinical contexts. First, dermal fibroblast cell-culture work characterizes collagen, elastin, and proteoglycan responses, summarized in our GHK-Cu dermal fibroblast research summary. Second, animal-model wound and tissue research uses GHK-Cu to study repair markers, angiogenesis, and matrix turnover, which our GHK-Cu wound research overview covers in detail. Third, mechanistic research into antioxidant biology, gene expression, and copper coordination uses GHK-Cu as a model copper-peptide system; the antioxidant work is captured in our GHK-Cu antioxidant research overview.

How Does GHK-Cu Compare to Other Copper Peptides in Research?

The copper-peptide research family extends beyond GHK to include AHK-Cu, IHL-Cu, and other small-peptide copper complexes used as model systems for understanding metal-peptide coordination biology. GHK-Cu's distinguishing features in comparative research include its natural origin in human plasma, its well-characterized binding affinity for copper(II), and the broad transcriptomic footprint it produces in cell-culture studies relative to simpler copper-peptide complexes. The skin and tissue research literature is reviewed in Frontiers in Pharmacology and our GHK-Cu skin aging research overview summarizes the comparative findings in skin-specific models. For combination studies that pair GHK-Cu with BPC-157 and TB-500 derivatives, see the GHK-Cu BPC-157 TB-500 combination skin research overview.

What Should Researchers Consider When Sourcing GHK-Cu 50mg?

Sourcing decisions for copper-peptide research start with documentation. A reputable supplier provides a batch-specific Certificate of Analysis showing 99 percent purity by HPLC, identity confirmation by mass spectrometry, and copper content verified by an appropriate analytical method. The label should be unambiguous about research-use-only status, and the lot number should be traceable across studies. Lyophilized GHK-Cu is typically stored frozen, protected from light and moisture; reconstituted material is refrigerated and used within the documented stability window. Midwest Peptide stocks the GHK-Cu 50mg research peptide with published Certificates of Analysis, alongside the GLOW peptide blend for combination studies. For a deeper supplier walkthrough, see our GHK-Cu sourcing guide.

Frequently Asked Questions

What distinguishes GHK-Cu 50mg from other copper peptides in research?

GHK-Cu is the copper(II) complex of the natural tripeptide Gly-His-Lys, present in human plasma. Compared with synthetic small-peptide copper complexes like AHK-Cu or IHL-Cu, GHK-Cu has a longer-established research literature, well-characterized copper coordination, and a broader transcriptomic footprint in cell-culture studies of dermal fibroblasts and tissue-remodeling models.

How should GHK-Cu 50mg be stored in a research lab?

Lyophilized GHK-Cu is stored frozen, protected from light and moisture, in a sealed container. Once reconstituted in bacteriostatic water or another approved diluent the solution is refrigerated at 2 to 8 degrees Celsius and used within the supplier's documented stability window, which spans a few weeks under proper handling. Limit freeze-thaw cycles to preserve copper coordination.

What preclinical models commonly use GHK-Cu?

The most common preclinical contexts are dermal fibroblast cell-culture systems characterizing collagen, elastin, and matrix metalloproteinase responses; rodent wound and tissue research models studying repair markers and angiogenesis; and gene expression and antioxidant biology studies using cultured cell systems with mass spectrometry, qPCR, and transcriptomic readouts.

What purity should research-grade GHK-Cu meet?

The working standard is 99 percent or higher peptide purity by HPLC, with identity confirmed by mass spectrometry on a batch-specific basis. Suppliers should also report copper content via an appropriate analytical method, since the copper coordination is essential for the research-relevant activity profile of the GHK-Cu complex.

Are there published studies using GHK-Cu in animal models?

Yes. The literature includes rodent skin and wound models, dermal fibroblast cultures spanning multiple cell-line backgrounds, and gene expression studies that characterize transcriptomic responses to GHK-Cu in controlled in-vitro conditions. The body of work continues to grow across copper-peptide pharmacology and tissue-remodeling research.

Can GHK-Cu be combined with other peptides in preclinical studies?

Yes. Combination protocols pair GHK-Cu with peptides like BPC-157 and TB-500-related sequences in skin and connective-tissue research models. Matched-supplier sourcing keeps purity and batch variation from confounding the results, and single-peptide control arms allow attribution of effects to the combination versus each peptide alone.

Where can researchers find documentation for GHK-Cu lots?

Documentation is provided by the supplier in the form of a batch-specific Certificate of Analysis. Reputable suppliers publish the COA on the product page itself, name the testing laboratory, disclose lot numbers, and report both peptide purity and copper content so the material can be traced and verified across studies.

Within the GHK-Cu cluster:

Not for human consumption. Research use only.

Age Verification

GHK-Cu 50mg in Research: Applications, Stability, and Findings